Related Experiment Videos
The role for stimulants in the treatment of depressive disorders
The Journal of Clinical Psychiatry
|August 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hepatotoxicity associated with maprotiline therapy: case report.
The Journal of clinical psychiatry·1984
Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report on Mechanism-Informed Pharmacologic Sequencing.
The Journal of clinical psychiatry·2026
Impact of Cannabis Use on Time to Psychiatric Rehospitalization in Young Adults With Bipolar and Psychotic Disorders: A Survival Analysis.
The Journal of clinical psychiatry·2026
The Role of Chronic Anhedonia in the Relationship Between Treatment-Resistant Depression and Suicidality.
The Journal of clinical psychiatry·2026
An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.
The Journal of clinical psychiatry·2026
Correction. Evaluation of Sexual Function With Adjunctive Lumateperone in Patients With Major Depressive Disorder.
The Journal of clinical psychiatry·2026
LRRC57/RABIN is a presynaptic inhibitor of Rab GTPases in glutamatergic neurons.
bioRxiv : the preprint server for biology·2026
A scoping review of adverse events associated with concomitant beta-adrenoreceptor blockers and selective serotonin reuptake inhibitors.
British journal of clinical pharmacology·2026
Optimal drug, dose and duration of antipsychotic therapy following amphetamine and cannabis-induced psychosis: A systematic review.
The Australian and New Zealand journal of psychiatry·2026
Effects of opioids and stimulants on the respiratory system.
European respiratory review : an official journal of the European Respiratory Society·2026